Bryn Mawr Trust Advisors LLC Buys Shares of 132,848 Nutrien Ltd. $NTR

Bryn Mawr Trust Advisors LLC bought a new position in Nutrien Ltd. (NYSE:NTRFree Report) in the second quarter, Holdings Channel.com reports. The institutional investor bought 132,848 shares of the company’s stock, valued at approximately $8,363,000.

Several other hedge funds have also modified their holdings of NTR. Guggenheim Capital LLC lifted its stake in Nutrien by 2.2% during the fourth quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock worth $409,000 after purchasing an additional 145 shares during the last quarter. Minot DeBlois Advisors LLC increased its stake in Nutrien by 1.8% in the fourth quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock valued at $557,000 after purchasing an additional 164 shares during the last quarter. Banque Cantonale Vaudoise raised its holdings in Nutrien by 15.9% during the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock worth $90,000 after purchasing an additional 164 shares in the last quarter. Gould Asset Management LLC CA raised its holdings in Nutrien by 4.4% during the first quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock worth $297,000 after purchasing an additional 165 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Nutrien by 21.8% during the 4th quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock worth $61,000 after buying an additional 176 shares during the last quarter. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Price Performance

NTR stock opened at $68.26 on Friday. The company has a market capitalization of $32.65 billion, a P/E ratio of 13.82, a PEG ratio of 0.67 and a beta of 0.61. Nutrien Ltd. has a twelve month low of $53.03 and a twelve month high of $85.36. The business has a 50 day simple moving average of $65.93 and a 200-day simple moving average of $70.39. The company has a current ratio of 1.39, a quick ratio of 0.86 and a debt-to-equity ratio of 0.36.

Nutrien (NYSE:NTRGet Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). The business had revenue of $10.81 billion for the quarter, compared to analysts’ expectations of $10.44 billion. Nutrien had a return on equity of 8.88% and a net margin of 8.44%.The business’s revenue was up 3.6% on a year-over-year basis. During the same quarter last year, the business posted $2.65 earnings per share. As a group, equities analysts anticipate that Nutrien Ltd. will post 5.01 EPS for the current year.

Nutrien Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 16th. Shareholders of record on Tuesday, September 29th will be given a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 3.2%. The ex-dividend date of this dividend is Tuesday, September 29th. Nutrien’s dividend payout ratio (DPR) is presently 44.53%.

Wall Street Analyst Weigh In

NTR has been the subject of several research analyst reports. Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of Nutrien in a report on Monday. Morgan Stanley cut their price target on shares of Nutrien from $93.00 to $81.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 7th. National Bank Financial reduced their price target on shares of Nutrien from $76.00 to $74.00 and set an “outperform” rating for the company in a research report on Monday, August 10th. Barclays decreased their price objective on shares of Nutrien from $81.00 to $78.00 and set an “overweight” rating for the company in a research note on Monday. Finally, TD Securities reaffirmed a “buy” rating on shares of Nutrien in a report on Wednesday, May 6th. Seventeen equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Nutrien has an average rating of “Moderate Buy” and a consensus price target of $81.58.

View Our Latest Analysis on NTR

Nutrien Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Read More

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.